miR-15a and 16-1 Are Downregulated in CD4⁺T Cells of Multiple Sclerosis Relapsing Patients

Barkhof F., 1999, Mult Scler, 5, 283, 10.1177/135245859900500415

Scholz C, 1998, J Immunol, 160, 1532, 10.4049/jimmunol.160.3.1532

Semra YK, 2002, J Neuroimmunol, 122, 1, 10.1016/S0165-5728(01)00445-3

Sharief MK, 2003, J Neuroimmunol, 134, 1, 10.1016/S0165-5728(02)00400-9

Shi Y, 2007, Nat Immunol, 8, 817, 10.1038/ni1489

10.1038/35037710

10.1146/annurev.biochem.69.1.217

International Multiple Sclerosis Genetics C, 2011, Nature, 476, 214, 10.1038/nature10251

Elizabeth PB, 2011, Annals of Neurology, 70, 886

Patsopoulos N, 2011, Annals of neurology, 70, 897, 10.1002/ana.22609

10.1084/jem.20061692

Huang B, 2009, EMBO Rep, 10, 180, 10.1038/embor.2008.224

10.1073/pnas.0506654102

Yazici H, 2009, J Oncol, 2009, 827532, 10.1155/2009/827532

Waiczies S, 2002, J Neuroimmunol, 126, 1, 10.1016/S0165-5728(02)00067-X

Wu H, 2007, PLoS ONE, 2, 1020, 10.1371/journal.pone.0001020

Yue JG, 2010, Mamm Genome, 21, 1, 10.1007/s00335-009-9241-2

Haegert DG, 2011, J Neuroimmunol, 233, 1, 10.1016/j.jneuroim.2010.12.007

Fabbri M, 2011, JAMA, 305, 59, 10.1001/jama.2010.1919

Fossey SC, 2007, J Mol Diagn, 9, 197, 10.2353/jmoldx.2007.060147

Deng X, 2005, Ann Neurol, 58, 577, 10.1002/ana.20600

Bomprezzi R, 2003, Hum Mol Genet, 12, 2191, 10.1093/hmg/ddg221

10.1038/nm0697-614

Achiron A, 2007, Ann N Y Acad Sci, 1107, 155, 10.1196/annals.1381.017

Satoh J, 2005, Neurobiol Dis, 18, 537, 10.1016/j.nbd.2004.10.007

Zettl UK, 1998, Neuropathol Appl Neurobiol, 24, 202, 10.1046/j.1365-2990.1998.00110.x

Okuda Y, 2006, J Neuroimmunol, 171, 1, 10.1016/j.jneuroim.2005.09.020

Rinta S, 2008, J Neuroimmunol, 205, 1, 10.1016/j.jneuroim.2008.09.002

Arthur A, 2008, BMC Med Genet, 9